Focus on Melanoma Meeting 2023
Friday 13th October 2023
Organised by: Professor Rowan Pritchard-Jones, Consultant Plastic Reconstructive Surgeon, and Executive Medical Director, Cheshire & Merseyside Integrated Care System
Location: The Royal College of Physicians, London
Registration for this event is now open
| Friday, 13th October 2023 | 9:00 am – 5:00 pm |
The year’s Focus on Melanoma meeting has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 5 category 1 (external) CPD credit(s).The British Association of Plastic, Reconstructive and Aesthetic Surgeons have awarded up to 5.5 CME credits. The Royal College of Surgeons of England has awarded up to 6 CPD points.
Poster abstracts to be submitted by Sunday 17th September 2023 (250 words maximum) to jenn@melanomafocus.org
Programme
| 09:00-09:55 | PIERRE FABRE SPONSORED PROMOTIONAL BREAKFAST SYMPOSIUM:
Decision-making in BRAF-mutant metastatic melanoma: an interactive review of case studies
Chair: Dr Pippa Corrie, Consultant Medical Oncologist, Cambridge University Hospitals NHS Foundation Trust – Dr Ricky Frazer, Consultant Medical Oncologist, Velindre Cancer Centre – Dr Matthew Wheater, Consultant Medical Oncologist, University Hospital Southampton NHS Foundation Trust
This promotional session is fully organised and funded by Pierre Fabre. Pierre Fabre products will be discussed at this meeting. |
| 10:00-10:05 | Welcome/Introductions -Dr Mark Harries, Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust and Chairman of Melanoma Focus -Professor Rowan Pritchard-Jones, Consultant Plastic Reconstructive Surgeon, and Executive Medical Director, Cheshire & Merseyside Integrated Care System |
| 10:05-10:15 | Melanoma Focus: Achievements and Plans Dr Mark Harries and Susanna Daniels |
| 10:15-11:40 | Session 1: Neoadjuvant treatment – Medical & Surgical Collaboration Chair: Professor Marc Moncrieff, Consultant Plastic Reconstructive Surgeon, Norfolk & Norwich University Hospitals NHS Foundation Trust |
| 10:15-10:45 | Neoadjuvant treatment Professor James Larkin, Consultant Medical Oncologist, Royal Marsden Hospital, London |
| 10:45-11:15 | Addressing Surgical concerns of Neoadjuvant Treatment Dr Vernon Sondak, Chair of the Department of Cutaneous Oncology, H Lee Moffitt Cancer Centre and Research Institute, Tampa, Florida |
| 11:15-11:35 | Q&A (20 minutes) |
| 11:35-12:00 | Break |
| 12:00-13:00 | Session 2: High risk primary disease and options beyond the obvious Chair: Rowan Pritchard-Jones, Consultant Plastic Reconstructive Surgeon, and Executive Medical Director, Cheshire & Merseyside Integrated Care System |
| 12:00-12:30 | High risk primary melanoma management -Mr Myles Smith, General Surgeon and Surgical Oncologist, Royal Marsden Hospital, London -Professor James Larkin, Consultant Medical Oncologist, Royal Marsden Hospital, London |
| 12:30 - 12:50 | Neoadjuvant ECT Dr Luca Campana, General Surgical Oncologist, Manchester Royal Infirmary |
| 12:50-13:00 | Q&A (10 minutes) |
| 13:00-14:00 | Lunch |
| 14:00-14:50 | Session 3: Panel Discussion: Does SLNB remain a meaningful staging procedure? Chair: Rowan Pritchard- Jones, Consultant Plastic Reconstructive Surgeon, and Executive Medical Director, Cheshire & Merseyside Integrated Care System
-Dr Anna Olsson-Brown, Consultant in Medical Oncology and Immunotherapy Service Lead, Clatterbridge Cancer Centre, Liverpool
-Professor Marc Moncrieff, Consultant Plastic Reconstructive Surgeon, Norfolk & Norwich University Hospitals NHS Foundation Trust
-Dr Vernon Sondak, Chair of the Department of Cutaneous Oncology, H Lee Moffitt Cancer Centre and Research Institute, Tampa, Florida |
| 14:50-15:35 | The Professor Martin Gore CBE Memorial Lecture:
Introduction – Dr Mark Harries, Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust and Chairman of Melanoma Focus
Multidisciplinary Management of Melanoma: Past, Present, and Future
Professor Charles Balch, Department of Surgical Oncology – Research, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 15:35-15:45 | Post NCRI- The UK Skin Cancer Clinical Trials Group Dr Brent O’Carrigan, Consultant Medical Oncologist, Cambridge University Hospitals NHS Trust |
| 15:45-16:55 | Session 5: MDT: Locally Advanced Disease Chair: Mr Howard Peach, Consultant, Consultant Plastic Surgeon, Leeds Teaching Hospitals NHS Trust
– Dr Vernon Sondak, Chair of the Department of Cutaneous Oncology, H Lee Moffitt Cancer Centre and Research Institute, Tampa, Florida
-Dr Anna Olsson-Brown, Consultant in Medical Oncology and Immunotherapy Service Lead, Clatterbridge Cancer Centre, Liverpool
-Dr Luca Campana, General Surgical Oncologist, Manchester Royal Infirmary
-Mr Myles Smith, General Surgeon and Surgical Oncologist, Royal Marsden Hospital, London
-Professor Catherine Harwood, Consultant Dermatologist, Barts Health NHS Trust |
| 16:55-17:00 | Close Professor Rowan Pritchard-Jones and Dr Mark Harries |